CompoAtlas

GestaMen

Food supplement declared in France, declaration No 2017-6-989

GestaMen is a food supplement declared in France. Status: retiré du marché le 18 February 2022. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
Gynea Laboratorios, S.L.U.
Status
Retiré du marché le 18 February 2022
Form
Capsule
Daily dose
1 capsule
Directions for use
prendre 1 capsule par jour avec un liquide

Declaration 281928, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Huile de poissonnot declared
Ubiquinonenot declared
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
Sélénite de sodiumSélénium255 µg50 µg
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Oxyde de zincZinc25 mg15 mg

Additives

E422, E322, E901, E172, E171

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

déconseillé aux individus allergiques au poisson et/ou présentant une intolérance aux additifs alimentaires.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line